Prescription drug · ANDA
Cyproheptadine Hydrochloride NDC 72162-2065
Cyproheptadine hydrochloride 2 mg/5mL · Solution · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72162-2065-2 | 72162206502 | 473 mL in 1 BOTTLE, GLASS (72162-2065-2)Marketed from Aug 12, 2024 | |
| 72162-2065-4 | 72162206504 | 473 mL in 1 BOTTLE, GLASS (72162-2065-4)Marketed from May 2, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cyproheptadine Hydrochloride
- Generic name (nonproprietary)
- cyproheptadine hydrochloride
- Active ingredients
- Cyproheptadine hydrochloride — 2 mg/5mL
- Dosage form
- Solution
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 212423
- Marketing start
- Listing expires
- Identifiers
- Product ID 72162-2065_34667b54-e4af-3fe6-e063-6294a90af0e1SPL ID 34667b54-e4af-3fe6-e063-6294a90af0e1SPL set ID 996dd4c6-ebcf-42e8-a950-9d34bb6f404fRxCUI 866021UNII NJ82J0F8QC
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472162206502followed by a unit qualifier and the quantityPackage 72162-2065-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Perennial and seasonal allergic rhinitis Vasomotor rhinitis Allergic conjunctivitis due to inhalant allergens and foods Mild, uncomplicated allergic skin manifestations of urticaria and angioedema Amelioration of allergic reactions to blood or plasma Cold urticaria Dermatographism As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 212423
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Cyproheptadine Hydrochloride | Cyproheptadine hydrochloride 2 mg/5mL | SolutionOral | QUAGEN PHARMACEUTICALS LLC | 70752-185 |
| Cyproheptadine Hydrochloride | Cyproheptadine hydrochloride 2 mg/5mL | SolutionOral | QUAGEN PHARMACEUTICALS LLC | 70752-101 |
| Cyproheptadine Hydrochloride | Cyproheptadine hydrochloride 2 mg/5mL | SolutionOral | Atlantic Biologicals Corp. | 17856-1185 |